Valuation: Vivos Therapeutics, Inc.

Market Cap 5.75M 5M 4.64M 4.28M 8.06M 549M 8.2M 54.92M 21.5M 273M 21.6M 21.12M 917M P/E 2026 *
-0.29x
P/E 2027 * -0.51x
Enterprise Value 5.75M 5M 4.64M 4.28M 8.06M 549M 8.2M 54.92M 21.5M 273M 21.6M 21.12M 917M EV / Sales 2026 *
0.24x
EV / Sales 2027 * 0.17x
Free-Float
73.65%
Yield 2026 *
-
Yield 2027 * -
1 day-1.93%
1 week+0.47%
Current month-10.69%
1 month-17.67%
3 months-48.13%
6 months-74.94%
Current year-80.00%
1 week 0.36
Extreme 0.3637
0.44
1 month 0.36
Extreme 0.3637
0.53
Current year 0.36
Extreme 0.3637
2.69
1 year 0.36
Extreme 0.3637
5.69
3 years 0.36
Extreme 0.3637
48.79
5 years 0.36
Extreme 0.3637
177.25
10 years 0.36
Extreme 0.3637
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 31/08/2016
Chief Executive Officer 68 31/08/2016
Director TitleAgeSince
Chairman 68 31/05/2020
Director/Board Member 87 31/05/2020
Director/Board Member 59 31/05/2020
Date Insider Type Main position Quantity % Market Cap.
30/06/26
Seneca Partners, Inc.
BuyCompany 2,749,330 19.7870%
30/06/26
Seneca Partners, Inc.
OtherCompany 2,749,330 19.7870%
04/02/26 Other

Director

3,997 0.0424%
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%+0.47%-90.90%-94.23% 5.75M
-0.09%+1.05%+40.80%+3.82% 12.59B
-0.84%+1.24%+20.06%+19.85% 6.67B
-0.91%+6.06%+51.99%+25.29% 5.99B
-1.39%+11.11% - - 5.17B
+0.58%+4.52%-24.10%+24.21% 4.55B
+1.01%+0.43%-20.98%-17.24% 4.09B
+0.20%-2.18%+33.89%-54.29% 1.77B
+4.41%+4.41%-12.25%+224.89% 1.72B
+2.77%-1.41%+55.28%-6.78% 1.51B
Average +0.05%+3.74%+5.98%+13.95% 4.41B
Weighted average by Cap. -0.25%+4.29%+22.77%+16.75%

Financials

2026 *2027 *
Net sales 24.06M 20.89M 19.4M 17.89M 33.71M 2.3B 34.32M 230M 89.94M 1.14B 90.34M 88.36M 3.84B 34.09M 29.61M 27.5M 25.36M 47.77M 3.25B 48.63M 326M 127M 1.62B 128M 125M 5.44B
Net income -23.82M -20.69M -19.21M -17.72M -33.37M -2.27B -33.98M -227M -89.05M -1.13B -89.44M -87.48M -3.8B -13.78M -11.97M -11.12M -10.25M -19.31M -1.32B -19.66M -132M -51.54M -654M -51.76M -50.63M -2.2B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
270
Date Price Change Volume
30/07/26 US$0.4059 -1.93% 40,429
29/07/26 US$0.4139 -1.45% 228,543
28/07/26 US$0.4200 +4.22% 232,407
27/07/26 US$0.4030 +2.52% 131,132
24/07/26 US$0.3931 +0.64% 152,919
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4059USD
Average target price
2.117USD
Spread / Average Target
+421.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock